MANKIND PHARMA
|
The Current P/S Ratio of MANKIND PHARMA is 7.92.
Share Price | ₹2,356.4 | Jun 09,2025 |
Market Cap | ₹97,246.6 Cr | |
Sales-TTM | ₹12,279.3 Cr | TTM-Consolidated Results |
Price/Sales | 7.92x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of MANKIND PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹97,246.6 Cr] as on Jun 09,2025
(/) Sales [ ₹12,279.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 7.92x ]
Thus, for MANKIND PHARMA , the investors are currently willing to pay '7.92 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of MANKIND PHARMA !
The chart below summarizes the trend in P/S Ratio of MANKIND PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of MANKIND PHARMA
PS Ratio Performance Analysis for MANKIND PHARMA
- MANKIND PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.78x.
- MANKIND PHARMA 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, MANKIND PHARMA 's p/e ratio peaked in Mar2024 at 8.9x.
- MANKIND PHARMA 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does MANKIND PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
MANKIND PHARMA | 12,279.3 | 7.92 | 97,246.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.73 | 406,519.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 18.79 | 175,903.0 |
CIPLA LTD | 27,547.6 | 4.42 | 121,669.0 |
TORRENT PHARMACEUTICALS LTD | 11,516.0 | 9.34 | 107,605.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.37 | 110,097.0 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.21 | 97,951.9 |
LUPIN LTD | 22,707.9 | 4.01 | 91,051.4 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.13 | 67,457.2 |
ABBOTT INDIA LTD | 6,409.2 | 10.55 | 67,600.5 |
ALKEM LABORATORIES LTD | 12,964.5 | 4.50 | 58,280.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs MANKIND PHARMA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.13x |
Max industry PS | 18.79x |
Median industry PS | 4.50x |
Average industry PS | 7.00x |
You may also like the below Video Courses